Renaissance Capital logo

ACCP News

US IPO Weekly Recap: 5 new filings while summer slowdown in full effect

SECO

No US IPOs priced this week. Filing activity remained muted with one Chinese luxury e-commerce company, two micro-cap healthcare deals, and two tech-focused SPACs joining the pipeline, while another mico-cap biotech withdrew. With the "active pipeline" at just 32 IPOs, the mounting backlog of pre-IPO companies (including those in our PCW) continue to delay...read more

Chemotherapy biotech Accelerated Pharma withdraws $8 million IPO after three attempts

ACCP

Accelerated Pharma, which is developing a chemotherapy optimized by genomic screening, withdrew its plans for an initial public offering on Wednesday. It had filed to raise $8 million by offering 1.5 million units at a price range of $4 to $6. The Westport, CT-based company was founded in 2014 and had planned to list on the Nasdaq under the symbol ACCP. Rodman & Renshaw...read more

US IPO Week Ahead: Chinese international school operator and 3 biotechs

BEDU

There are four deals on the calendar for the week ahead. Chinese international school operator Bright Scholar Education is leading the week with a $135 million offering. Three biotechs are also expected to price deals, raising a total of $177 million. ...read more

US IPO Week Ahead: Gardner Denver's $1 billion IPO leads week with 7 offerings

GDI

Seven deals are on the IPO calendar to raise $1.7 billion in week ahead. Industrial parts manufacturer Gardner Denver leads the pack with a $1.0 billion offering, while California real estate developer Five Point and oilfield equipment provider ...read more